25,000+ successful transplants, 90%+ success rates for liver, kidney, heart, lung, pancreas, paediatric, and multi organ procedures for international patients from 50+ countries.
Looking for a specific insurance provider? Simply use our search function or contact us for assistance and our knowledgeable team will happily verify whether your provider is accepted at our facility.
Ask about your insurance
Yes. For kidney transplants, ABO incompatible transplants are available using specialised desensitisation protocols, meaning a transplant is possible even without a blood matched donor.
For patients with no living donor, Apollo is registered with India's organ allocation system and is one of the most active recipients of deceased donor organs in the country.
Share your blood type, crossmatch results, and donor situation with My 1Health for specific guidance.
Apollo's international team provides a specific estimate once your transplant plan is confirmed.
Apollo has a confirmed 90%+ success rate across kidney, liver, and multi organ transplants, backed by 20,000+ solid organ procedures.
It has been the world's busiest solid organ transplant programme since 2013.
Apollo performed India's first kidney transplant (1984), first adult liver transplant (1998), and first paediatric liver transplant (1998).
The child who received that 1998 paediatric transplant qualified as a doctor in 2021.
Costs vary by organ type, complexity, living versus deceased donor, length of stay, and clinical needs.
Kidney, liver, BMT, heart, lung, pancreas, corneal, and intestinal transplants each carry different cost structures.
India is considerably lower than equivalent care in the USA, UK, Germany, or the Gulf, with equivalent volumes, success rates, and accreditation.
Share your reports with My 1Health for a written estimate before any travel decision.
Apollo has performed 21,000+ solid organ transplants and holds every major Indian transplant first:
ABO incompatible transplant capability is confirmed.
The network spans 21 transplant centres, meaning patients from Bangladesh, Bhutan, and Myanmar can access Apollo Kolkata or Guwahati rather than travelling to Delhi or Mumbai.
Apollo Navi Mumbai's transplant team has published 400+ peer reviewed papers.